Categories
Marijuana

CV Sciences Inc. (OTCMKTS:CVSI) Enters Distribution Partnership With Southeastern Grocers

CV Sciences Inc. (OTCMKTS:CVSI) and Southeastern Grocers Inc. have announced a distribution partnership for PlusCBD Oil Topical Products as well as Dietary Supplements. The initial launch will be at the 115 Winn-Dixies in Florida and South Carolina’s 37 BI-LO stores. The PlusCBD Oil topical products have been available in the stores since November 3.

Distribution partnership to enhance the availability of CV Sciences CBD products

The new distribution agreement between CV Sciences and Southeastern Grocers enhances the distribution and availability of CV Sciences’ wide range of products. The broad range of products also includes ingestible dietary supplements besides PlusCBD Oil. The new distribution in BI-LO outlets in South Carolina and some Winn-Dixie outlets in Florida includes topical products such as PlusCBD Oil Roll-On, and PlusCBD Oil Extra Strength and Original Balm. There are also PlusCBD Oil full-spectrum hemp supplements such as Gold Formula Drops and Gummies, Gold Formula as well as Total Plant Complex Sprays.

CV Sciences CEO Joseph Dowling indicated that they are delighted to expand the distribution through the partnership with Southeastern Grocers. The agreement will enable the company to bring its topical products and dietary supplements to the mass food and retail channel. The CEO added that after the initial launch, they expect more distribution gains in Florida and Colorado.

CV Sciences receives an award for best supplements

In September, the company indicated that it had received the “NEXTY consumer Choice Award” in the dietary supplement category for its PlusCBD Oil Total Plant Complex Peppermint Spray. The award given annually at the Natural Products Expo East and West acknowledges innovative and inspirational natural products. Products that win the award are determined through consumer feedback that sample and ward scores to the products.

The Company’s PlusCBD Oil has best-selling CBD supplement in the Total US Natural Channel. The Extra Strength is ranked first in sales in the Total US MULO and Total US Natural Channel alongside CBD products in Topical Analgesics. The BD topicals market is growing fast, and according to Brightfield Group, the market will be worth $1.3 billion this year.

Categories
Marijuana

CV Sciences Inc. (OTCMKTS:CVSI) To File Request For Continued Examination of Its 15/426,617 Patent Application

CV Sciences Inc. (OTCMKTS:CVSI) has announced that it plans to submit a Request of Continued Examination of its 15/426,617 patent application with the US Patent Trademark Office. The patent is titled Pharmaceutical Formulations Containing Cannabidiol and Nicotine For Treating Smokeless Tobacco Addiction.

Filing for an RCE

The intention to file for a Request of Continued Examination comes after the USPTO notified CV Sciences that the Patent Trial and Appeal Board declined their appeal to reverse the decision of the examiner to deny specific claims that were made in the company’s patent application.

The Chief Executive Officer of CV Sciences, Joseph Dowling, stated that the decision of USPTO was disappointing. It was important to note that it was not the end of the process. He added that the company plans to make the request continued examination. He said that they are confident in the protection of the company’s intellectual property regarding the formulation as well as the ability of CV Sciences to commercialize the invention.

Dowling indicated that they believe the innovation will offer a solution to the persistent epidemic in smokeless tobacco addiction. He added that the company would remain focused on the development of proprietary products that can enhance the quality of life of its customers.

PlusCBD Oil leading product in the CBD market

CV Sciences runs two different business segments which are consumer product divisions and the drug development division. The consumer division focuses on manufacturing, selling, and marketing of their CBD products to different markets. The drug development segment focuses on the development and commercialization of innovative CBD-based therapeutics, that utilize CBD.

The company’s PlusCBD oil is top-selling hemp-derived CBD product, and according to the CEO, consumers choose the product because of its quality, purity, and consistency. Dowling indicates that the company offers a premium product line of gluten-free and non-GMO full spectrum CBD products in the market. CV Science’s full-spectrum hemp extracts are produced, tested, and processed in the company’s state of the art facility, to ensure products conform to its standards.

Pin It on Pinterest